Advertisement

Topics

Technomark Group Company Profile

00:38 EST 17th December 2018 | BioPortfolio

The hallmark of our reputation is the quality and experience of our senior consultants who are the cornerstone of our success. With qualifications in either medicine, science, finance, law or business, each consultant will already have spent a significant time working in the pharmaceutical or related industries. When Technomark was founded in 1987, our purpose was to meet the growing demand for business solutions in pharmaceutical R&D and to provide guidance to growing CROs. Since then we have undertaken consultancy assignments in all areas of the life science industry from early stage drug development and clinical research to commercial manufacturing and marketing in the European, North American and Asia Pacific regions. We have built a solid reputation, as consultants who can apply technical, commercial, financial and business expertise to the life science industries, especially pharmaceuticals.
Every project that we undertake is led by one of our senior consultants and they have regular meetings with colleagues to discuss progress and thus benefit from a multi-disciplinary forum. We are not in the business of providing abstract conclusions based on stock answers. Our reports make innovative and practical recommendations with candid and honest advice based on current information and first hand experience.
We provide a first-class service to each of our customers in the life science sector on an international basis. We combine our expertise and experience to provide the best possible solutions to the problems of each customer. Our approach is to forge strong long term partnerships that deliver value in terms of punctuality, quality and costs.

Location

1 Deans Yard
London
Westminster
SW1P 3NP
United Kingdom

Contact

Phone: 44 (0) 20 7340 1010
Fax: 44 (0) 20 7340 1029
Email: gmoxon@technomark.com


News Articles [662 Associated News Articles listed on BioPortfolio]

Incanthera secures further investment

Liverpool cancer treatment specialist Incanthera has raised at least £650,000 as it prepares its treatment for clinical trials.Existing investor, the European Union-backed North West Fund for B...

Zur Rose Group announces result of rights take-up

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 28.11.2018 / 17:35 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Zur Rose Group successfully concludes rights issue and announces offer price of CHF 93 per new share

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 29.11.2018 / 07:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Maricann Group Inc.: Mit Volldampf in die Zukunft! - CEO Ben Ward gibt Ausblick über hervorragende Entwicklung der Wayland Group

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP-Media / 2018-11-21 / 10:42 *Unternehmen: Wayland Group (ehemals Maricann Group.....

Delek Group Announces Consolidated Second Quarter 2018 Results

TEL AVIV, Israel, Aug. 30, 2018 /PRNewswire/ -- Delek Group Ltd. (TASE: DLEKG) (OTC: DGRLY) (hereinafter: "Delek Group" or "The Group") announced today its results Read more...

#Cannabisstocks: Cronos Group (NASDAQ: $CRON) (TSX: $CRON.TO) Confirms Discussions Regarding Potential Investment by Altria Group (NYSE: $MO)

TORONTO - December 4, 2018 (Investorideas.com Newswire) Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") confirmed that it is engaged in discussions concerning a potentia...

Maricann Group Inc.: Sensations Coup! Einstieg in argentinischen Cannabis Markt - Wayland Group erwirbt über 800 Hektar Anbaufläche!

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP-Media / 2018-12-11 / 07:20 *Unternehmen: Wayland Group (ehemals Maricann Group.....

Capital increase of Zur Rose Group: Further information on the rights issue

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 03.12.2018 / 06:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

PubMed Articles [1741 Associated PubMed Articles listed on BioPortfolio]

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

Isolation and exploitation of minority: Game theoretical analysis.

We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size differ...

Group I introns are widespread in archaea.

Group I catalytic introns have been found in bacterial, viral, organellar, and some eukaryotic genomes, but not in archaea. All known archaeal introns are bulge-helix-bulge (BHB) introns, with the exc...

The role of group cohesion in a group-based behavioral weight loss intervention.

Behavioral weight loss interventions are often delivered in groups. Group cohesion may enhance program attendance and, thereby, weight loss. In this secondary analysis, our goals were to: (1a) assess ...

Experimental animal study of docetaxel combined with carboplatin in the treatment of retinoblastoma.

The synergistic effects of docetaxel (DTX) combined with carboplatin in the treatment of retinoblastoma (RB) was explored in mouse RB xenografts compared with carboplatin alone and DTX alone groups. R...

Clinical Trials [4119 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Ultrasound and Exercises in Knee Osteoarthritis

The aim of this investigation is to compare the effects of continuous (CUS) and pulsed (PUS) ultrasound associated with a program of exercises on pain, range of motion, muscle strength, fu...

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

The T2T Study of RA Based on SSDM

This study evaluate the Smart System of Disease Management(SSDM)to improve the treat-to-target(T2T) and the safety of drug in the treatment of rheumatoid(RA). All participants will be ...

Companies [1644 Associated Companies listed on BioPortfolio]

Technomark Consulting Services Limited

Technomark Consulting is an innovative, specialist consultancy group, dedicated to offering customised responses to the needs of our clients (pharmaceutical and biotechnology companies, CROs, CPMs, in...

Technomark Consulting Services Ltd

Founded in 1987 to meet the needs of a pharmaceutical industry undergoing major restructuring, Technomark's mission was to provide guidance to pharmaceutical companies looking to outsource their resea...

Technomark Group

The hallmark of our reputation is the quality and experience of our senior consultants who are the cornerstone of our success. With qualifications in either medicine, science, finance, law or business...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

More Information about "Technomark Group" on BioPortfolio

We have published hundreds of Technomark Group news stories on BioPortfolio along with dozens of Technomark Group Clinical Trials and PubMed Articles about Technomark Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Technomark Group Companies in our database. You can also find out about relevant Technomark Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record